CNR1 and type 2 diabetes mellitus: CB1R antagonists/inverse agonists are potential beneficial adjuvants to lifestyle modification and weight reduction in the control of carbohydrate and lipid homeostasis to prevent dyslipidemia and hyperglycemia in obese and T2D patients.